Consensus opinion on immune-mediated cytopenias after hematopoietic cell transplant for inherited metabolic disorders

Hematopoietic stem cell transplantation (HCT) has been increasingly used for patients with inherited metabolic disorders (IMD). Immune mediated cytopenias (IMCs) after HCT, manifesting as hemolytic anemia, thrombocytopenia, and/or neutropenia, are recognized as a significant complication in this pat...

Cijeli opis

Spremljeno u:
Bibliografski detalji
Izdano u:Bone Marrow Transplant
Glavni autori: Gupta, Ashish O., Jan Boelens, Jaap, Ebens, Christen L., Kurtzberg, Joanne, Lund, Troy C., Smith, Angela R., Wagner, John E., Wynn, Robert, Blazar, Bruce R., Orchard, Paul J.
Format: Artigo
Jezik:Inglês
Izdano: Nature Publishing Group UK 2021
Teme:
Perspective
Online pristup:https://ncbi.nlm.nih.gov/pmc/articles/PMC8189901/
https://ncbi.nlm.nih.gov/pubmed/33441980
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/s41409-020-01179-5
Oznake: Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!

Similar Items